Indeed, Zhao et al determined that via competitive glucose consumption, ovarian cancer can induce expression of specific micro-RNAs in CD4+ and CD8+ T cells of the tumor microenvironment, which suppress the expression of EZH2 and decrease their survival and immune function [96]. The gene discussed is CD4; the disease is neoplasm.